Tau PET the best tool to predict rate of cognitive decline in Alzheimer’s

Tau PET is the best imaging tool to predict the rate of cognitive decline in Alzheimer’s, researchers asserted in a new study published Aug. 9.

Read More


Alzheimer’s Agent Fails; Antiseizure Drug Use Rises; Stress and Post-COVID Outcomes

Phase III studies of investigational gantenerumab did not meet their primary endpoints of slowing clinical decline in early Alzheimer’s disease, the Roche Group said. Beta-amyloid removal also was lower than expected with the drug.

Read More


Detecting Alzheimer’s Gets Easier with a Simple Blood Test

Source: Advances in technologies to detect early signs of disease from a blood sample are helping doctors to identify the memory-robbing disorder more accurately and to screen participants more quickly for trials of potential treatments.

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.